
Human Blood Plasma Fractionation - Global and China Top Players Market Share and Ranking 2025
Discover the latest insights into the booming Human Blood Plasma Fractionation Market. This report analyzes market size, growth trends (CAGR 7.10%), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for 2024-2031.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Human Blood Plasma Fractionation market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Human Blood Plasma Fractionation Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Human Blood Plasma Fractionation Market by Type [Analysis by Value from 2020 to 2031]:
- Immune Globulin
- Coagulation Factor
- Albumin
- Others
Human Blood Plasma Fractionation Market by Application [Analysis by Value from 2020 to 2031]:
- Hospital
- Retail Pharmacy
- Others
Key Players in the Human Blood Plasma Fractionation Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Human Blood Plasma Fractionation Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Human Blood Plasma Fractionation Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Human Blood Plasma Fractionation Market Size & Demand Forecast (2031)
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Human Blood Plasma Fractionation Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Human Blood Plasma Fractionation Segmentation & Growth Forecasts
The study systematically breaks down the Global Human Blood Plasma Fractionation Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Human Blood Plasma Fractionation Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Human Blood Plasma Fractionation market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Human Blood Plasma Fractionation Definition
1.2 Global Human Blood Plasma Fractionation Market Size and Forecast
1.3 China Human Blood Plasma Fractionation Market Size and Forecast
1.4 Share of China Human Blood Plasma Fractionation Market with Respect to the Global Market
1.5 Human Blood Plasma Fractionation Market Size: China VS Global Growth Rate, 2020-2031
1.6 Human Blood Plasma Fractionation Market Dynamics
1.6.1 Human Blood Plasma Fractionation Market Drivers
1.6.2 Human Blood Plasma Fractionation Market Restraints
1.6.3 Human Blood Plasma Fractionation Industry Trends
1.6.4 Human Blood Plasma Fractionation Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Human Blood Plasma Fractionation, Global Market Share by Company, 2020-2025
2.2 Global Human Blood Plasma Fractionation Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Human Blood Plasma Fractionation Concentration Ratio
2.4 Global Human Blood Plasma Fractionation Mergers & Acquisitions, Expansion Plans
2.5 Global Human Blood Plasma Fractionation Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Human Blood Plasma Fractionation, China Market Share by Company, 2020-2025
3.2 China Human Blood Plasma Fractionation Human Blood Plasma Fractionation Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Human Blood Plasma Fractionation Industry Chain
4.2 Human Blood Plasma Fractionation Upstream Analysis
4.2.1 Human Blood Plasma Fractionation Core Raw Materials
4.2.2 Main Manufacturers of Human Blood Plasma Fractionation Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Human Blood Plasma Fractionation Production Mode
4.6 Human Blood Plasma Fractionation Procurement Model
4.7 Human Blood Plasma Fractionation Industry Sales Model and Sales Channels
4.7.1 Human Blood Plasma Fractionation Sales Model
4.7.2 Human Blood Plasma Fractionation Typical Distributors
5 Sights by Type
5.1 Human Blood Plasma Fractionation Classification
5.1.1 Immune Globulin
5.1.2 Coagulation Factor
5.1.3 Albumin
5.1.4 Others
5.2 by Type, Global Human Blood Plasma Fractionation Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031
6 Sights by Application
6.1 Human Blood Plasma Fractionation Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Others
6.2 by Application, Global Human Blood Plasma Fractionation Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031
7 Sales Sights by Region
7.1 By Region, Global Human Blood Plasma Fractionation Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Human Blood Plasma Fractionation Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Human Blood Plasma Fractionation Market Size Market Share
7.4 Europe
7.4.1 Europe Human Blood Plasma Fractionation Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Human Blood Plasma Fractionation Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Human Blood Plasma Fractionation Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Human Blood Plasma Fractionation Market Size Market Share
7.6 South America
7.6.1 South AmericaHuman Blood Plasma Fractionation Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Human Blood Plasma Fractionation Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Human Blood Plasma Fractionation Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Human Blood Plasma Fractionation Market Size, 2020-2031
8.3.2 by Type, United States Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Human Blood Plasma Fractionation Market Size, 2020-2031
8.4.2 by Type, Europe Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Human Blood Plasma Fractionation Market Size, 2020-2031
8.5.2 by Type, China Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Human Blood Plasma Fractionation Market Size, 2020-2031
8.6.2 by Type, Japan Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Human Blood Plasma Fractionation Market Size, 2020-2031
8.7.2 by Type, South Korea Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Human Blood Plasma Fractionation Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Human Blood Plasma Fractionation Market Size, 2020-2031
8.9.2 by Type, India Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Human Blood Plasma Fractionation Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
9 Company Profile
9.1 Takeda
9.1.1 Takeda Company Information, Head Office, Market Area, and Industry Position
9.1.2 Takeda Company Profile and Main Business
9.1.3 Takeda Human Blood Plasma Fractionation Models, Specifications, and Application
9.1.4 Takeda Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.1.5 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Company Information, Head Office, Market Area, and Industry Position
9.2.2 CSL Company Profile and Main Business
9.2.3 CSL Human Blood Plasma Fractionation Models, Specifications, and Application
9.2.4 CSL Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.2.5 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Company Information, Head Office, Market Area, and Industry Position
9.3.2 Grifols Company Profile and Main Business
9.3.3 Grifols Human Blood Plasma Fractionation Models, Specifications, and Application
9.3.4 Grifols Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.3.5 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
9.4.2 Octapharma Company Profile and Main Business
9.4.3 Octapharma Human Blood Plasma Fractionation Models, Specifications, and Application
9.4.4 Octapharma Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Company Information, Head Office, Market Area, and Industry Position
9.5.2 Kedrion Company Profile and Main Business
9.5.3 Kedrion Human Blood Plasma Fractionation Models, Specifications, and Application
9.5.4 Kedrion Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Company Information, Head Office, Market Area, and Industry Position
9.6.2 LFB Group Company Profile and Main Business
9.6.3 LFB Group Human Blood Plasma Fractionation Models, Specifications, and Application
9.6.4 LFB Group Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Company Information, Head Office, Market Area, and Industry Position
9.7.2 Biotest Company Profile and Main Business
9.7.3 Biotest Human Blood Plasma Fractionation Models, Specifications, and Application
9.7.4 Biotest Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Company Information, Head Office, Market Area, and Industry Position
9.8.2 BPL Company Profile and Main Business
9.8.3 BPL Human Blood Plasma Fractionation Models, Specifications, and Application
9.8.4 BPL Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.8.5 BPL Recent Developments
9.9 RAAS
9.9.1 RAAS Company Information, Head Office, Market Area, and Industry Position
9.9.2 RAAS Company Profile and Main Business
9.9.3 RAAS Human Blood Plasma Fractionation Models, Specifications, and Application
9.9.4 RAAS Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.9.5 RAAS Recent Developments
9.10 CBPO
9.10.1 CBPO Company Information, Head Office, Market Area, and Industry Position
9.10.2 CBPO Company Profile and Main Business
9.10.3 CBPO Human Blood Plasma Fractionation Models, Specifications, and Application
9.10.4 CBPO Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.10.5 CBPO Recent Developments
9.11 Hualan Bio
9.11.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
9.11.2 Hualan Bio Company Profile and Main Business
9.11.3 Hualan Bio Human Blood Plasma Fractionation Models, Specifications, and Application
9.11.4 Hualan Bio Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.11.5 Hualan Bio Recent Developments
9.12 Tiantan Bio
9.12.1 Tiantan Bio Company Information, Head Office, Market Area, and Industry Position
9.12.2 Tiantan Bio Company Profile and Main Business
9.12.3 Tiantan Bio Human Blood Plasma Fractionation Models, Specifications, and Application
9.12.4 Tiantan Bio Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.12.5 Tiantan Bio Recent Developments
9.13 Shuanglin Bio
9.13.1 Shuanglin Bio Company Information, Head Office, Market Area, and Industry Position
9.13.2 Shuanglin Bio Company Profile and Main Business
9.13.3 Shuanglin Bio Human Blood Plasma Fractionation Models, Specifications, and Application
9.13.4 Shuanglin Bio Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.13.5 Shuanglin Bio Recent Developments
9.14 Boya Bio
9.14.1 Boya Bio Company Information, Head Office, Market Area, and Industry Position
9.14.2 Boya Bio Company Profile and Main Business
9.14.3 Boya Bio Human Blood Plasma Fractionation Models, Specifications, and Application
9.14.4 Boya Bio Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.14.5 Boya Bio Recent Developments
9.15 Yuanda Shuyang
9.15.1 Yuanda Shuyang Company Information, Head Office, Market Area, and Industry Position
9.15.2 Yuanda Shuyang Company Profile and Main Business
9.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Models, Specifications, and Application
9.15.4 Yuanda Shuyang Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.15.5 Yuanda Shuyang Recent Developments
9.16 Weiguang Bio
9.16.1 Weiguang Bio Company Information, Head Office, Market Area, and Industry Position
9.16.2 Weiguang Bio Company Profile and Main Business
9.16.3 Weiguang Bio Human Blood Plasma Fractionation Models, Specifications, and Application
9.16.4 Weiguang Bio Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.16.5 Weiguang Bio Recent Developments
9.17 Nanyue Bio
9.17.1 Nanyue Bio Company Information, Head Office, Market Area, and Industry Position
9.17.2 Nanyue Bio Company Profile and Main Business
9.17.3 Nanyue Bio Human Blood Plasma Fractionation Models, Specifications, and Application
9.17.4 Nanyue Bio Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.17.5 Nanyue Bio Recent Developments
9.18 KM Biologics
9.18.1 KM Biologics Company Information, Head Office, Market Area, and Industry Position
9.18.2 KM Biologics Company Profile and Main Business
9.18.3 KM Biologics Human Blood Plasma Fractionation Models, Specifications, and Application
9.18.4 KM Biologics Human Blood Plasma Fractionation Revenue and Gross Margin, 2020-2025
9.18.5 KM Biologics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Human Blood Plasma Fractionation Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Human Blood Plasma Fractionation Market Restraints
Table 3. Human Blood Plasma Fractionation Market Trends
Table 4. Human Blood Plasma Fractionation Industry Policy
Table 5. Global Human Blood Plasma Fractionation Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Human Blood Plasma Fractionation Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Human Blood Plasma Fractionation Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Human Blood Plasma Fractionation Mergers & Acquisitions, Expansion Plans
Table 9. Global Human Blood Plasma Fractionation Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Human Blood Plasma Fractionation Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 12. China Human Blood Plasma Fractionation Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Human Blood Plasma Fractionation Upstream (Raw Materials)
Table 14. Global Human Blood Plasma Fractionation Typical Customers
Table 15. Human Blood Plasma Fractionation Typical Distributors
Table 16. by Type, Global Human Blood Plasma Fractionation Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. by Application, Global Human Blood Plasma Fractionation Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Human Blood Plasma Fractionation Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 19. By Region, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Table 20. By Country, Global Human Blood Plasma Fractionation Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Table 22. By Country, Global Human Blood Plasma Fractionation Consumption Value Market Share, 2020-2031
Table 23. Takeda Company Information, Head Office, Market Area, and Industry Position
Table 24. Takeda Company Profile and Main Business
Table 25. Takeda Human Blood Plasma Fractionation Models, Specifications, and Application
Table 26. Takeda Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 27. Takeda Recent Developments
Table 28. CSL Company Information, Head Office, Market Area, and Industry Position
Table 29. CSL Company Profile and Main Business
Table 30. CSL Human Blood Plasma Fractionation Models, Specifications, and Application
Table 31. CSL Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 32. CSL Recent Developments
Table 33. Grifols Company Information, Head Office, Market Area, and Industry Position
Table 34. Grifols Company Profile and Main Business
Table 35. Grifols Human Blood Plasma Fractionation Models, Specifications, and Application
Table 36. Grifols Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 37. Grifols Recent Developments
Table 38. Octapharma Company Information, Head Office, Market Area, and Industry Position
Table 39. Octapharma Company Profile and Main Business
Table 40. Octapharma Human Blood Plasma Fractionation Models, Specifications, and Application
Table 41. Octapharma Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 42. Octapharma Recent Developments
Table 43. Kedrion Company Information, Head Office, Market Area, and Industry Position
Table 44. Kedrion Company Profile and Main Business
Table 45. Kedrion Human Blood Plasma Fractionation Models, Specifications, and Application
Table 46. Kedrion Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 47. Kedrion Recent Developments
Table 48. LFB Group Company Information, Head Office, Market Area, and Industry Position
Table 49. LFB Group Company Profile and Main Business
Table 50. LFB Group Human Blood Plasma Fractionation Models, Specifications, and Application
Table 51. LFB Group Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 52. LFB Group Recent Developments
Table 53. Biotest Company Information, Head Office, Market Area, and Industry Position
Table 54. Biotest Company Profile and Main Business
Table 55. Biotest Human Blood Plasma Fractionation Models, Specifications, and Application
Table 56. Biotest Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 57. Biotest Recent Developments
Table 58. BPL Company Information, Head Office, Market Area, and Industry Position
Table 59. BPL Company Profile and Main Business
Table 60. BPL Human Blood Plasma Fractionation Models, Specifications, and Application
Table 61. BPL Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 62. BPL Recent Developments
Table 63. RAAS Company Information, Head Office, Market Area, and Industry Position
Table 64. RAAS Company Profile and Main Business
Table 65. RAAS Human Blood Plasma Fractionation Models, Specifications, and Application
Table 66. RAAS Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 67. RAAS Recent Developments
Table 68. CBPO Company Information, Head Office, Market Area, and Industry Position
Table 69. CBPO Company Profile and Main Business
Table 70. CBPO Human Blood Plasma Fractionation Models, Specifications, and Application
Table 71. CBPO Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 72. CBPO Recent Developments
Table 73. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
Table 74. Hualan Bio Company Profile and Main Business
Table 75. Hualan Bio Human Blood Plasma Fractionation Models, Specifications, and Application
Table 76. Hualan Bio Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 77. Hualan Bio Recent Developments
Table 78. Tiantan Bio Company Information, Head Office, Market Area, and Industry Position
Table 79. Tiantan Bio Company Profile and Main Business
Table 80. Tiantan Bio Human Blood Plasma Fractionation Models, Specifications, and Application
Table 81. Tiantan Bio Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 82. Tiantan Bio Recent Developments
Table 83. Shuanglin Bio Company Information, Head Office, Market Area, and Industry Position
Table 84. Shuanglin Bio Company Profile and Main Business
Table 85. Shuanglin Bio Human Blood Plasma Fractionation Models, Specifications, and Application
Table 86. Shuanglin Bio Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 87. Shuanglin Bio Recent Developments
Table 88. Boya Bio Company Information, Head Office, Market Area, and Industry Position
Table 89. Boya Bio Company Profile and Main Business
Table 90. Boya Bio Human Blood Plasma Fractionation Models, Specifications, and Application
Table 91. Boya Bio Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 92. Boya Bio Recent Developments
Table 93. Yuanda Shuyang Company Information, Head Office, Market Area, and Industry Position
Table 94. Yuanda Shuyang Company Profile and Main Business
Table 95. Yuanda Shuyang Human Blood Plasma Fractionation Models, Specifications, and Application
Table 96. Yuanda Shuyang Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 97. Yuanda Shuyang Recent Developments
Table 98. Weiguang Bio Company Information, Head Office, Market Area, and Industry Position
Table 99. Weiguang Bio Company Profile and Main Business
Table 100. Weiguang Bio Human Blood Plasma Fractionation Models, Specifications, and Application
Table 101. Weiguang Bio Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 102. Weiguang Bio Recent Developments
Table 103. Nanyue Bio Company Information, Head Office, Market Area, and Industry Position
Table 104. Nanyue Bio Company Profile and Main Business
Table 105. Nanyue Bio Human Blood Plasma Fractionation Models, Specifications, and Application
Table 106. Nanyue Bio Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 107. Nanyue Bio Recent Developments
Table 108. KM Biologics Company Information, Head Office, Market Area, and Industry Position
Table 109. KM Biologics Company Profile and Main Business
Table 110. KM Biologics Human Blood Plasma Fractionation Models, Specifications, and Application
Table 111. KM Biologics Human Blood Plasma Fractionation Revenue and Gross Margin, US$ Million, 2020-2025
Table 112. KM Biologics Recent Developments
List of Figures
Figure 1. Human Blood Plasma Fractionation Picture
Figure 2. Global Human Blood Plasma Fractionation Consumption Value, (US$ million) & (2020-2031)
Figure 3. China Human Blood Plasma Fractionation Consumption Value, (US$ million) & (2020-2031)
Figure 4. By Consumption Value, China Human Blood Plasma Fractionation Market Share of Global, 2020-2031
Figure 5. Global Human Blood Plasma Fractionation Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 6. China Human Blood Plasma Fractionation Key Participants, Market Share, 2024
Figure 7. Human Blood Plasma Fractionation Industry Chain
Figure 8. Human Blood Plasma Fractionation Procurement Model
Figure 9. Human Blood Plasma Fractionation Sales Model
Figure 10. Human Blood Plasma Fractionation Sales Channels, Direct Sales, and Distribution
Figure 11. Immune Globulin
Figure 12. Coagulation Factor
Figure 13. Albumin
Figure 14. Others
Figure 15. by Type, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 16. by Type, Global Human Blood Plasma Fractionation Consumption Value Market Share, 2020-2031
Figure 17. Hospital
Figure 18. Retail Pharmacy
Figure 19. Others
Figure 20. by Application, Global Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 21. by Application, Global Human Blood Plasma Fractionation Revenue Market Share, 2020-2031
Figure 22. By Region, Global Human Blood Plasma Fractionation Consumption Value Market Share, 2020-2031
Figure 23. North America Human Blood Plasma Fractionation Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 24. By Country, North America Human Blood Plasma Fractionation Consumption Value Market Share, 2024
Figure 25. Europe Human Blood Plasma Fractionation Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 26. By Country, Europe Human Blood Plasma Fractionation Consumption Value Market Share, 2024
Figure 27. Asia Pacific Human Blood Plasma Fractionation Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 28. By Country/Region, Asia Pacific Human Blood Plasma Fractionation Consumption Value Market Share, 2024
Figure 29. South America Human Blood Plasma Fractionation Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 30. By Country, South America Human Blood Plasma Fractionation Consumption Value Market Share, 2024
Figure 31. Middle East & Africa Human Blood Plasma Fractionation Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 32. United States Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 33. by Type, United States Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 34. by Application, United States Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 35. Europe Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 36. by Type, Europe Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 37. by Application, Europe Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 38. China Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 39. by Type, China Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 40. by Application, China Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 41. Japan Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 42. by Type, Japan Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 43. by Application, Japan Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 44. South Korea Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 45. by Type, South Korea Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 46. by Application, South Korea Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 47. Southeast Asia Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 48. by Type, Southeast Asia Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 49. by Application, Southeast Asia Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 50. India Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 51. by Type, India Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 52. by Application, India Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 53. Middle East & Africa Human Blood Plasma Fractionation Consumption Value, 2020-2031, US$ Million
Figure 54. by Type, Middle East & Africa Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 55. by Application, Middle East & Africa Human Blood Plasma Fractionation Consumption Value Market Share, 2024 VS 2031
Figure 56. Research Methodology
Figure 57. Breakdown of Primary Interviews
Figure 58. Bottom-up Approaches
Figure 59. Top-down Approaches
Research Methodology:
Human Blood Plasma Fractionation Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|